• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Establishing the First Mobile Stroke Unit in the United States Special Reports
Conclusion— The first MSU in the United States has been introduced in Houston, TX. The steps needed to accomplish this are described.
Source: Stroke - April 27, 2015 Category: Neurology Authors: Parker, S. A., Bowry, R., Wu, T.-C., Noser, E. A., Jackson, K., Richardson, L., Persse, D., Grotta, J. C. Tags: CT and MRI, Thrombolysis Special Reports Source Type: research

Suitability of the 6CIT as a screening test for dementia in primary care patients.
Conclusion: The 6CIT's psychometric properties in a real-world setting suggest that the test is not suited as a routine screening instrument. Factors inherent to screening in primary care likely contributed to its low reliability and validity. This highlights the need for training GPs in the conduct of cognitive screening before such procedures can be implemented on a routine basis. PMID: 24256425 [PubMed - as supplied by publisher]
Source: Aging and Mental Health - November 20, 2013 Category: Geriatrics Authors: Hessler J, Brönner M, Etgen T, Ander KH, Förstl H, Poppert H, Sander D, Bickel H Tags: Aging Ment Health Source Type: research

Review of Therapeutic Electrical Stimulation for Dorsiflexion Assist and Orthotic Substitution From the American Congress of Rehabilitation Medicine Stroke Movement Interventions Subcommittee
This article provides clinicians with information to guide them in the use of electrical stimulation orthotic substitute devices, discusses current research about the use of electrical stimulation orthotic substitute devices for therapeutic and orthotic purposes, and compares the use of electrical stimulation orthotic substitute devices and AFOs. There is insufficient evidence thus far to conclude that walking with an electrical stimulation orthotic substitute device is superior to walking with an AFO, but electrical stimulation orthotic substitute devices may be the optimal choice for some patients.
Source: Archives of Physical Medicine and Rehabilitation - November 8, 2013 Category: Rehabilitation Authors: Pamela Rogers Bosch, Jocelyn E. Harris, Kay Wing, American Congress of Rehabilitation Medicine (ACRM) Stroke Movement Interventions Subcommittee Tags: Clinical Management Review Source Type: research

A review of therapeutic electrical stimulation for dorsiflexion assist and for orthotic substitution from the ACRM Stroke Movement Interventions Subcommittee.
Abstract Ankle dorsiflexion weakness that impedes walking affects some 30 percent of people after a stroke, increasing the risk of falls and mortality. Recent advances in functional electrical stimulation or in electrical stimulation orthotic-substitute (eSOS) walking devices facilitate the use of surface electrode stimulation during therapeutic gait training and as an orthotic substitute. However, many therapists who could promote the use of these eSOS devices are not doing so, possibly due to a lack of knowledge about the devices and uncertainty about which patients could benefit from the devices, but also due t...
Source: Medical Physics - November 5, 2013 Category: Physics Authors: Bosch PR, Harris JE, Wing MK Tags: Arch Phys Med Rehabil Source Type: research

If you could propose one idea to help improve health care delivery in the United States, what would it be?
Thumbnail: Tags: conversationsphrma conversationslarry hausnermyrl weinbergchris hansennancy brownContributors: 11621161115911631173Contributions: Read Larry Hausner's bio Despite the rapid development of innovative technologies in the health care field, we have yet to discover a panacea that will easily transform our health care system into one that provides high-quality and cost-effective care.  What we have discovered and come to agree on over the last decade is that our sick care system must be reconfigured to a health care system that emphasizes wellness and prevention.  For that reason, I offer ...
Source: PHRMA - June 24, 2013 Category: Pharmaceuticals Authors: rlowe Source Type: news

Guidelines for the Intravenous Application of Recombinant Tissue-type Plasminogen Activator (Alteplase), the Second Edition, October 2012: A Guideline From the Japan Stroke Society
In Japan, intravenous alteplase, a recombinant tissue-type plasminogen activator (rt-PA), was approved for an indication of ischemic stroke in 2005 on the basis of the results of a clinical trial with a unique dose of the drug (0.6 mg/kg). The Japan Stroke Society published the guidelines for intravenous application of rt-PA and organized training sessions for proper use all over Japan in an effort to promote the safe, widespread use of intravenous alteplase. Seven years following its approval, clinical experience with intravenous alteplase has accumulated, additional evidence of intravenous alteplase has been found in Jap...
Source: Journal of Stroke and Cerebrovascular Diseases - June 3, 2013 Category: Neurology Authors: Kazuo Minematsu, Kazunori Toyoda, Teruyuki Hirano, Kazumi Kimura, Rei Kondo, Etsuro Mori, Jyoji Nakagawara, Nobuyuki Sakai, Yoshiaki Shiokawa, Norio Tanahashi, Masahiro Yasaka, Yasuo Katayama, Susumu Miyamoto, Akira Ogawa, Makoto Sasaki, Sadao Suga, Taken Tags: Original Articles Source Type: research

Pages: 1  2  3